Position in JNJ
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$11,514,999
+$198,161 QoQ
Shares Held
45,340
-2.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.03%
of 13F equity value
Holder Rank
#1,022
of 4,659 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FOSTER & MOTLEY INC holds $58,493,564 across 11 Drug Manufacturers - General names. JNJ ranks #3 (19.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
57,981 | $14,590,338 | |
| 2 | AMGN |
Amgen Inc
|
32,896 | $11,912,299 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
45,340 | $11,514,999 | |
| 4 | MRK |
Merck & Co., Inc.
|
38,282 | $4,919,237 | |
| 5 | PFE |
Pfizer Inc
|
168,239 | $4,051,195 | |
| 6 | NVS |
Novartis AG
|
21,447 | $3,361,173 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
56,454 | $3,252,879 | |
| 8 | GSK |
GSK plc
|
42,484 | $2,227,011 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,514,999 | 45,340 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $11,316,838 | 46,297 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $9,780,870 | 47,262 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $8,939,839 | 48,214 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $7,543,558 | 49,385 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $8,024,500 | 48,387 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $6,766,625 | 46,789 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $7,559,126 | 46,644 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $6,976,362 | 47,731 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $7,345,236 | 46,433 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $7,187,626 | 45,857 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $6,739,769 | 43,273 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $7,339,984 | 44,345 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $6,894,245 | 44,479 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $8,017,966 | 45,389 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $7,370,476 | 45,118 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $8,130,490 | 45,803 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $8,346,115 | 47,092 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $8,289,367 | 48,456 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $7,837,918 | 48,532 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $8,158,913 | 49,526 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $8,017,157 | 48,781 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $7,567,774 | 48,086 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $6,548,040 | 43,982 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $6,342,413 | 45,100 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $6,049,944 | 46,137 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||